Crossmark

Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study

Crossref DOI link: https://doi.org/10.1016/j.medcli.2015.09.020

Published Print: 2016-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ruiz-de-Adana, María Soledad

Dominguez-Lopez, Marta-Elena

Gonzalez-Molero, Inmaculada

Machado, Alberto

Martin, Victor

Cardona, Isabel

de-la-Higuera, Magdalena

Tapia, María-José

Soriguer, Federico

Anarte, María Teresa

Rojo-Martínez, Gemma
Funding

Funding for this research was provided by:

Fondo de Investigación Sanitaria

Junta de Andalucía
License Information

Text and Data Mining valid from 2016-03-01
More Information

This article is maintained by: Elsevier

Article Title: Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2015.09.020

Content Type: article

Copyright: Copyright © 2015 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below